Predicted amorphous solubility and dissolution rate advantages following moisture sorption: Case studies of indomethacin and felodipine

Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs

Stability is an essential quality attribute of any pharmaceutical formulation. Poor stability can change the color and physical appearance of a drug, directly impacting the patient's perception. Unstable drug products may also face loss of active pharmaceutical ingredients (APIs) and degradation, making the medicine ineffective and toxic. Moisture content is known to be the leading cause of the degradation of nearly 50% of medicinal products, leading to impurities in solid dose formulations. The polarity of the atoms in an API and the surface chemistry of API particles majorly influence the affinity towards water molecules. Moisture induces chemical reactions, including free water that has also been identified as an important factor in determining drug product stability. Among the various approaches, crystal engineering and specifically co-crystals, have a proven ability to increase the stability of moisture-sensitive APIs. Other approaches, such as changing the salt form, can lead to solubility issues, thus making the co-crystal approach more suited to enhancing hygroscopic stability. There are many reported studies where co-crystals have exhibited reduced hygroscopicity compared to pure API, thereby improving the product's stability. In this review, the authors focus on recent updates and trends in these studies related to improving the hygroscopic stability of compounds, discuss the reasons behind the enhanced stability, and briefly discuss the screening of co-formers for moisture-sensitive drugs.

Bioavailability and toxicity of silver nanoparticles: Determination based on toxicokinetic-toxicodynamic processes

Determining the bioavailability and toxicity mechanism of silver nanoparticles (AgNPs) is challenging as Ag⁺ is continuously released by external or internal AgNP dissolution in the actual exposure system (regardless of the laboratory or the natural environment). Here a novel pulsed-gradient Ag⁺ (AgNO₃) exposure was conducted with zebrafish (Danio rerio) larvae to simulate dissolved gradient concentrations of Ag⁺ from polyvinylpyrrolidone (PVP)-coated AgNPs. The accumulation and toxicity of the pulsed-gradient Ag⁺ (AgNO₃) and, in the meantime, the released Ag⁺ from PVP-AgNPs were predicted using a toxicokinetic-toxicodynamic (TK-TD) model with obtained Ag⁺ parameters. In order to further understand the possible mechanism of PVP-AgNP releasing Ag⁺ in the body, subcellular fractions (S9) of zebrafish were also used to incubate with AgNPs in vitro to mimic the realistic in vivo scenarios. In the TK process, in vivo analysis showed that AgNPs released around twice as many Ag⁺ into the body than were detected with a single Ag⁺ pulse-exposure system; this was supported by evidence that subcellular S9 fractions might cause the PVP-AgNPs to lose the capping agent and favor Ag⁺ release. In the TD process, toxicity (survival rate) was predicted by the total bodily Ag(I) concentration, suggesting that AgNP toxicity in larvae was mainly due to gradually released Ag⁺ rather than AgNPs themselves. This study helps clarify the role of Ag⁺ in AgNP toxicity and offers a novel framework by which to investigate the toxicity of metal nanoparticles and corresponding metal ions in biological systems.

Unleashing the Biological Potential of Fomes fomentarius via Dry and Wet Milling

Fomes fomentarius, usually referred to as tinder conk, is a common wood-based fungus rich in many interesting phytochemicals and with an unique porous structure. Dry or wet ball milling of this sponge on a planetary mill results in small particles with sizes in the range of 10 µm or below. Suspended in water and without preservatives or other stabilizers, the resulting micro-suspensions are sterile for around six days, probably due to the increased temperatures of around 80 °C especially during the wet milling process. The suspensions also exhibit excellent antioxidant activities as determined in the DPPH, ferric reducing antioxidant potential (FRAP) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) assays. In the DPPH assay, IC₅₀ values of 0.02–0.04% w/v and 0.04% w/v were observed for dry and wet milled samples, respectively. In the FRAP assay, IC₅₀ values of <0.02% w/v and 0.04% w/v were observed for dry and wet milled samples, respectively. In contrast, the ABTS assay provided IC₅₀ values of 0.04% w/v and 0.005% w/v, respectively. Notably, this activity is mostly—albeit not exclusively—associated with the highly porous particles and their large surfaces, although some active ingredients also diffuse into the surrounding aqueous medium. Such suspensions of natural particles carrying otherwise insoluble antioxidants on their surfaces provide an interesting avenue to unleash the antioxidant potential of materials such as sponges and barks. As dry milling also enables longer storage and transport, applications in the fields of medicine, nutrition, agriculture, materials and cosmetics are feasible.

Estimating the maximal solubility advantage of drug salts

Salt formation can enable the development of poorly water-soluble drugs containing at least one ionizable moiety. Not only can salts offer a solubility enhancement that can sometimes far exceed that of other commonly used solubilization strategies applied across the pharmaceutical industry, they can simultaneously bestow additional benefits such as providing low-cost formulation options. The goal of this work is to put forth a simple methodology to enable one to accurately predict the maximal solubility advantage of acidic and basic drugs whose unionized conjugate (neutral parent molecule) is poorly soluble. While published equations leveraging the Henderson-Hasselbalch/H-H relationship reasonably estimate the thermodynamic solubility limit (in systems where there is no supersaturation), under physiologically relevant conditions the maximal/kinetic solubility can play an important role in determining oral bioavailability, as in the case of amorphous drugs. Under these circumstances, a higher solubility can be maintained for short durations through drug supersaturation provided that the precipitation is slow, thereby causing deviations from H-H predictions. It is possible also that, in some instances, supersaturation could coincide with behavior previously attributed to drug aggregation in solution. The proposed methodology utilizes speciation across the pH range to allow one to determine the maximal amount of ionized and unionized drug in solution at each pH. The calculation is easily extended to cases where the counterion serves as a competing weak acid, weak base, or as a common ion. Additionally, a more thorough assessment of the Gibbs free energy change associated with the solubilization of salts is also presented, as this energy describes the key driving force for the recrystallization of the neutral parent by triggering its nucleation. Lastly, to demonstrate applicability to real-world compounds containing multiple ionizable moieties, the complex pH-solubility profile of a drug maleate salt taken from the literature is simulated.

Manufacturing strategies to develop amorphous solid dispersions: An overview

Since the past several decades, poor water solubility of existing and new drugs in the pipeline have remained a challenging issue for the pharmaceutical industry. Literature describes several approaches to improve the overall solubility, dissolution rate, and bioavailability of drugs with poor water solubility. Moreover, the development of amorphous solid dispersion (SD) using suitable polymers and methods have gained considerable importance in the recent past. In the present review, we attempt to discuss the important and industrially scalable thermal strategies for the development of amorphous SD. These include both solvent (spray drying and fluid bed processing) and fusion (hot melt extrusion and KinetiSol®) based techniques. The current review also provides insights into the thermodynamic properties of drugs, their polymer miscibility and solubility, and their molecular dynamics to develop stable and more efficient amorphous SD.